Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Invested Capital (2020 - 2025)

Rani Therapeutics Holdings has reported Invested Capital over the past 6 years, most recently at $41.5 million for Q4 2025.

  • Quarterly results put Invested Capital at $41.5 million for Q4 2025, up 124.47% from a year ago — trailing twelve months through Dec 2025 was $41.5 million (up 124.47% YoY), and the annual figure for FY2025 was $41.5 million, up 124.47%.
  • Invested Capital for Q4 2025 was $41.5 million at Rani Therapeutics Holdings, up from $5.7 million in the prior quarter.
  • Over the last five years, Invested Capital for RANI hit a ceiling of $132.0 million in Q3 2021 and a floor of -$122.8 million in Q2 2021.
  • Median Invested Capital over the past 5 years was $33.2 million (2023), compared with a mean of $35.1 million.
  • Biggest five-year swings in Invested Capital: surged 208.67% in 2021 and later crashed 72.37% in 2025.
  • Rani Therapeutics Holdings' Invested Capital stood at $121.7 million in 2021, then plummeted by 39.19% to $74.0 million in 2022, then tumbled by 59.0% to $30.3 million in 2023, then tumbled by 39.05% to $18.5 million in 2024, then surged by 124.47% to $41.5 million in 2025.
  • The last three reported values for Invested Capital were $41.5 million (Q4 2025), $5.7 million (Q3 2025), and $5.8 million (Q2 2025) per Business Quant data.